Cargando…

Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach

A plethora of dynamic pathophysiological mechanisms underpins highly heterogeneous phenotypes in the field of dementia, particularly in Alzheimer’s disease (AD). In such a faceted scenario, a biomarker-guided approach, through the implementation of specific fluid biomarkers individually reflecting d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Prete, Eleonora, Beatino, Maria Francesca, Campese, Nicole, Giampietri, Linda, Siciliano, Gabriele, Ceravolo, Roberto, Baldacci, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712586/ https://www.ncbi.nlm.nih.gov/pubmed/33187336 http://dx.doi.org/10.3390/jpm10040221

Ejemplares similares

Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments
por: Giampietri, Linda, et al.
Publicado: (2022)

Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals
por: Stoccoro, Andrea, et al.
Publicado: (2022)

Mild Behavioral Impairment in Psychogeriatric Patients: Clinical Features and Psychopathology Severity
por: Elefante, Camilla, et al.
Publicado: (2023)

Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-C
por: Bellini, Gabriele, et al.
Publicado: (2021)

Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review
por: Palermo, Giovanni, et al.
Publicado: (2021)

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
por: Palermo, Giovanni, et al.
Publicado: (2020)

Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease
por: De Luca, Ciro, et al.
Publicado: (2021)

Morphometric imaging and quantitative susceptibility mapping as complementary tools in the diagnosis of parkinsonisms
por: Mazzucchi, Sonia, et al.
Publicado: (2022)

Understanding the Multiple Role of Mitochondria in Parkinson’s Disease and Related Disorders: Lesson From Genetics and Protein–Interaction Network
por: Nicoletti, Valentina, et al.
Publicado: (2021)

A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer’s Disease
por: Zhong, Xiaofang, et al.
Publicado: (2019)

Identification of Candidate Biomarkers of Alzheimer’s Disease via Multiplex Cerebrospinal Fluid and Serum Proteomics
por: Liu, Ping, et al.
Publicado: (2023)

α-Synuclein Heterocomplexes with β-Amyloid Are Increased in Red Blood Cells of Parkinson’s Disease Patients and Correlate with Disease Severity
por: Daniele, Simona, et al.
Publicado: (2018)

CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
por: De Luca, Ciro, et al.
Publicado: (2021)

P041. Analysis of body mass index, psychiatric comorbidity, sleep-wake pattern and occurrence of fatigue in episodic and chronic migraine patients
por: Lucchesi, Cinzia, et al.
Publicado: (2015)

MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
por: Müller, Mareike, et al.
Publicado: (2015)

Mitochondrial D-Loop Region Methylation and Copy Number in Peripheral Blood DNA of Parkinson’s Disease Patients
por: Stoccoro, Andrea, et al.
Publicado: (2021)

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian Disorders
por: Constantinescu, Radu, et al.
Publicado: (2013)

Dissecting Migraine: The Future of Anatomical, Functional, and Liquid Biomarkers
por: De Luca, Ciro, et al.
Publicado: (2022)

A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
por: Hampel, Harald, et al.
Publicado: (2020)

Botulinum toxin for the treatment of dystonia and pain in corticobasal syndrome
por: Unti, Elisa, et al.
Publicado: (2019)

MicroRNAs as Candidate Biomarkers for Alzheimer’s Disease
por: Kanach, Colin, et al.
Publicado: (2021)

Current state of Alzheimer’s fluid biomarkers
por: Molinuevo, José Luis, et al.
Publicado: (2018)

From small studies to precision medicine: prioritizing candidate biomarkers
por: Gaile, Daniel P, et al.
Publicado: (2013)

Freezing of gait and dementia in parkinsonism: A retrospective case–control study
por: Palermo, Giovanni, et al.
Publicado: (2019)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

Alix: A Candidate Serum Biomarker of Alzheimer’s Disease
por: Sun, Yingni, et al.
Publicado: (2021)

Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia
por: Galgani, Alessandro, et al.
Publicado: (2022)

Exploring the clinical association between neurological symptoms and COVID-19 pandemic outbreak: a systematic review of current literature
por: Di Carlo, Davide Tiziano, et al.
Publicado: (2020)

Fluid biomarkers in Alzheimer’s disease – current concepts
por: Rosén, Christoffer, et al.
Publicado: (2013)

Clinical significance of fluid biomarkers in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2020)

Impact of ApoE Polymorphism and Physical Activity on Plasma Antioxidant Capability and Erythrocyte Membranes
por: Piccarducci, Rebecca, et al.
Publicado: (2019)

Biomarker Candidates for Alzheimer’s Disease Unraveled through In Silico Differential Gene Expression Analysis
por: Silva-Lucero, Maria-del-Carmen, et al.
Publicado: (2022)

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
por: Cicognola, Claudia, et al.
Publicado: (2016)

Can agrin cerebrospinal fluid concentration be used as an early biomarker for Alzheimer's disease?
por: Del Campo Milan, Marta, et al.
Publicado: (2015)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

The Past and the Future of Alzheimer’s Disease Fluid Biomarkers(1)
por: Blennow, Kaj, et al.
Publicado: (2018)

Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017)

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
por: Omar, Syed Haris, et al.
Publicado: (2020)

Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
por: Nguyen, Thuy Trang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lij0tpta9fvhv8opdgupbm4oci